Rocky Mountain Poison & Drug Safety provides specialized research, education, prevention, and treatment services designed to ensure safety, reduce risk, safeguard compliance, and galvanize industry innovation. Our comprehensive services span the lifecycle of a drug or consumer product and are designed to meet the unique and complex needs of public health, government agencies, and the pharmaceutical and consumer products industries.

Established in 1956, Rocky Mountain Poison & Drug Safety, a department within Denver Health, has a long-standing reputation for excellence and expertise in the field of toxicology. Over the years, we have worked with a wide range of client organizations, creatively solving problems to meet the ever-changing landscape of the drug and consumer products industries.

We invite you to learn more by visiting our website at rmpds.org.

Health Care

Pharmaceutical

Research

Rocky Mountain Poison & Drug Safety (RMPDS)

Richard Dart

Brandon Ensign

Nancy Botiller

The Research and Analysis team at Rocky Mountain Poison & Drug Safety (RMPDS) specializes in designing, conducting, and interpreting complex research studies related to toxicology, public health, and pharmaceutical safety. This team integrates data management, statistical analysis, and scientific research to provide insights that support evidence-based decision-making, regulatory compliance, and industry innovation. They collaborate closely with other departments and external stakeholders to ensure accurate and impactful research outcomes that enhance public safety and advance the field of toxicology.

Research and Analysis

Strategy and Development

Program and Change Management

Research and Analysis

About

Team members

Other teams at Rocky Mountain Poison & Drug Safety (RMPDS)

Strategy and Development

Program and Change Management